USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/4509
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPântea, V.
dc.contributor.authorCebotarescu, V.
dc.contributor.authorSmeşnoi, V.
dc.date.accessioned2019-06-25T16:32:39Z-
dc.date.available2019-06-25T16:32:39Z-
dc.date.issued2011
dc.identifier.citationPANTEA, V., CEBOTARESCU, V., SMESNOI, V. Citomix în tratamentul hepatitei virale C cronice. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 12-a. Chişinau: СEP Medicina, 2011, vol. 3: Probleme actuale în medicina internă, pp. 372-376.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/4509-
dc.descriptionCatedrea Boli infecţioase FECMF a USMF "Nicolae Testemiţanu" IMSP SCBI "T. Ciorbă"en_US
dc.description.abstractThe treatment with cytomix of 30 patients with chronic viral hepatitis C, for the duration of 4 months contributed to the, improvement till the disappearance of clinical symptoms; the improvement of cytolysis syndrome indices, which indicates in favour of hepatoprotective features of the drug; a moderate decreasing of anti-HVC IgM titres with a bias in 2 was found; an improvement of the immune status was seen until a normal one to 66,6% of the patients enroled in the study, which confirm immunomodulatory proprieties of the drug. Key words: Cytomix, Treatment, Chronic Viral Hepatitis C. Tratamentul cu Cytomix la 30 pacienţi cu diagnosticul Hepatită virală C cronică, cu o durată de 4 luni a contribuit la ameliorarea simptomatologiei clinice, la ameliorarea indicilor sindromului citolitic, ceia ce pledează în favoarea efectului hepatoprotector al remediului. Scăderea moderată a titrului de anti-HVC IgM urmărită la unele cazuri, ameliorarea indicilor statutului imun, iar la 66,6% din pacienţii aflaţi în studiu, normalizarea acestora, demonstrează efectul imunomodilator al preparatuluien_US
dc.language.isootheren_US
dc.publisherCEP Medicinaen_US
dc.subjectCytomixen_US
dc.subject.meshHepatitis C, Chronicen_US
dc.subject.meshHepatoprotective Agents - therapeutic useen_US
dc.titleCitomix în tratamentul hepatitei virale C croniceen_US
dc.title.alternativeThe Cytomix in Treatment of Patients with Chronic Viral Hepatitis Cen_US
dc.typeArticleen_US
Appears in Collections:Boli infecțioase

Files in This Item:
File Description SizeFormat 
CITOMIX_IN_TRATAMENTUL_HEPATITEI_VIRALE_C_CRONICE.pdf160.48 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback